Rekombinanter SARS-CoV-2 Nucleocapsid Antikörper (Biotin)
Kurzübersicht für Rekombinanter SARS-CoV-2 Nucleocapsid Antikörper (Biotin) (ABIN7272896)
Target
Alle SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N) Antikörper anzeigenAntikörpertyp
Fragment
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Expressionssystem
- E.coli
-
Spezifität
- Nucleocapsid from SARS-CoV-2 and SARS-CoV-1
-
Aufreinigung
- Produced in: E.coli
-
Immunogen
- Our nanobody binds strongly to protein N of SARS-CoV-2, even under harsh sample treatment conditions, e.g. paraffin-embedded tissue.
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Reconsitute with 250 µL 50% glycerol for storage at -80 °C
-
Buffer
- sdAbs are lyophilized from PBS pH 7.4.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Vials containing lyophilized protein can be stored at 4°C for up to 6 months. Vials containing reconstituted protein should be stored at -20°C or below.
-
-
- SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N)
-
Andere Bezeichnung
- Nucleocapsid from SARS-CoV-2
-
Hintergrund
- The nucleocapsid (N) protein of SARS-CoV-2 is an abundant RNA-binding protein critical for the packaging of the single-stranded RNA viral genome. Due to its abundance, it is an interesting target for antibody detection in biopsies and tissue. The protein N is also present inside virion particles bound to single-stranded RNA.
Target
-